GlaxoSmithKline recalls 593,000 asthma inhalers: no China involved

Because of its convenient carrying and low price, the asthma inhaler is a must-have medicine for the asthma patient group, and it is also a life-saving medicine for sudden emergencies. For the multinational pharmaceutical giant GlaxoSmithKline (GSK) to recall the defective asthma inhaler involved in China, on April 6, GlaxoSmithKline (China) company responded to Caixin reporter, the recall is limited to the United States, because Defective products are only available to the US and have nothing to do with the Chinese market.

In China, the trade name of the Ventolin asthma inhaler is aspirin and Vantolin. The generic drug is a salbutamol sulfate aerosol produced by Yamagata Toyo Pharmaceutical, but the generic market share is very small, basically not right. The original drug poses a competitive threat.

On April 4th, US time, GlaxoSmithKline said that the company will take the initiative to recall 593,000 salolinamine (Ventolin) asthma inhalers from US hospitals, pharmacies, retailers and wholesalers because of the defects of these inhalers. , may result in insufficient dose of the drug inhaled by the patient.

GlaxoSmithKline says that product defects do not pose a risk to the patient, so GlaxoSmithKline will not ask the user to return the inhaler that has already been purchased.

葛兰素史克召回59.3万只哮喘吸入器:不涉及中国

GlaxoSmithKline said that the company has received a number of product complaint reports that the outer packaging of its asthma inhaler has expanded, which means that the propellant used to push the drug leaks. The Ventolin Asthma inhaler is an aerosol administered by a quantitative compression device consisting of an aluminum alloy bottle filled with a metering valve, a drive and a dust cover.

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s initiative to launch a “secondary” recall program that involves three batches of Ventolin HFA 200D inhalers, mainly from GlaxoSmithKline’s Factory in Zebulon, North Carolina.

The inhaler is still in production at the Zebulon plant. GlaxoSmithKline spokesman Juan Carlos Molina said the incident would not affect the supply of the Ventolin HFA 200D inhaler, while GlaxoSmithKline is trying to find this The root of the problem and will take appropriate action accordingly.

The Ventolin Asthma inhaler is a star product of GlaxoSmithKline. Since its introduction in 1969, this product has been rapidly promoted globally and has become a classic drug for the treatment of acute asthma. In the asthma drug sales list, GlaxoSmithKline also firmly controlled the status of asthma drug leader with this fist product and subsequent upgrade products.

Other Urology Instruments

We're professional Other Urology Instruments manufacturers and suppliers in China, specialized in providing high quality medical instruments with reasonable price. We warmly welcome you to buy or wholesale bulk Other Urology Instruments for sale here and get quotation from our factory.

Urology Fistula Needle,Urology Penile Clamps,Urology Dressing Forceps,Urethral Filar Sound Dilator

Tonglu WANHE Medical Instrument Co., Ltd , https://www.tlvanhurhealth.com